Ssg Pharma Profile
Key Indicators
- Authorised Capital ₹ 21.00 Cr
as on 22-12-2024
- Paid Up Capital ₹ 9.16 Cr
as on 22-12-2024
- Company Age 27 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 10.00 Cr
as on 22-12-2024
- Satisfied Charges ₹ 11.51 Cr
as on 22-12-2024
- Revenue -5.29%
(FY 2024)
- Profit 15.95%
(FY 2024)
- Ebitda 3.50%
(FY 2024)
- Net Worth 20.99%
(FY 2024)
- Total Assets 14.08%
(FY 2024)
About Ssg Pharma
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 21.00 Cr and a paid-up capital of Rs 9.16 Cr.
The company currently has active open charges totaling ₹10.00 Cr. The company has closed loans amounting to ₹11.51 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anil Mittal, Sunil Mittal, Navansh Mittal, and One other member serve as directors at the Company.
- CIN/LLPIN
U24100DL1997PTC085245
- Company No.
085245
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Feb 1997
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Ssg Pharma Private Limited offer?
Ssg Pharma Private Limited offers a wide range of products and services, including Juices, Soups & Soft Drinks, Fruit Juice, Snacks and Namkeen, Nut Snack and Popcorn, Digestive System Drugs & Medicines, Digestive Drugs, Namkeen, Ayurvedic,Herbal Products & Medicine, Ayurvedic Tablets, Snack Foods.
Who are the key members and board of directors at Ssg Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Navansh Mittal  | Director | 29-Sep-2012 | Current |
| Anil Mittal | Whole-Time Director | 22-Feb-1997 | Current |
| Sunil Mittal | Whole-Time Director | 22-Feb-1997 | Current |
| Vidul Mittal | Director | 01-Apr-2017 | Current |
Financial Performance of Ssg Pharma.
Ssg Pharma Private Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 5.29% decrease. The company also saw a substantial improvement in profitability, with a 15.95% increase in profit. The company's net worth Soared by an impressive increase of 20.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ssg Pharma?
In 2024, Ssg Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Oct 2018 | ₹10.00 Cr | Open |
Others Creation Date: 12 Jan 2018 | ₹5.00 Cr | Satisfied |
Others Creation Date: 15 Mar 2007 | ₹6.00 Cr | Satisfied |
How Many Employees Work at Ssg Pharma?
Ssg Pharma has a workforce of 299 employees as of Dec 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ssg Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ssg Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
